Product Code: ETC406857 | Publication Date: Oct 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States Animal Model Market is a rapidly growing industry driven by the increasing demand for animal models in biomedical research, drug development, and testing. Key factors contributing to this growth include advancements in genetic engineering technologies, rising prevalence of chronic diseases, and the need for personalized medicine. The market is segmented based on type (mice, rats, rabbits, etc.), application (research, drug discovery, toxicology), and end-user (pharmaceutical companies, academic institutions, research organizations). With a strong presence of leading biotechnology and pharmaceutical companies, research institutions, and government funding for life sciences research, the US Animal Model Market is poised for continued expansion. However, ethical concerns, animal welfare regulations, and the emergence of alternative technologies such as in vitro models present challenges to market growth.
The US Animal Model Market is experiencing several key trends, including a growing demand for genetically modified animal models for research purposes, particularly in the fields of drug development and personalized medicine. There is also a shift towards the use of humanized animal models to better mimic human physiology and disease conditions. Additionally, the market is witnessing an increasing focus on reducing the use of traditional animal models in favor of more ethical and sustainable alternatives such as organoids and in vitro models. Furthermore, there is a rising adoption of advanced technologies like CRISPR/Cas9 gene editing to create more precise and reliable animal models. Overall, these trends indicate a move towards more sophisticated, ethical, and efficient animal models in the US research market.
In the US Animal Model Market, challenges primarily stem from ethical considerations surrounding the use of animals in research, leading to increasing pressure from animal rights groups and regulatory bodies. This creates a complex regulatory landscape that researchers must navigate to ensure compliance while also facing the rising costs associated with maintaining and using animal models. Additionally, variability in animal responses, genetic differences, and the potential for discrepancies between animal models and human outcomes present obstacles to the accurate translation of research findings. Furthermore, the need for continuous innovation in animal model development to better mimic human physiology poses a challenge in terms of time and resources. Overall, balancing ethical concerns, regulatory requirements, cost considerations, and scientific accuracy remains a significant challenge in the US Animal Model Market.
The United States Animal Model Market presents various investment opportunities for companies involved in pharmaceuticals, biotechnology, and research industries. With a growing demand for animal models in drug development, disease modeling, and preclinical testing, there is a need for innovative and specialized animal model services and products. Investing in companies that provide genetically engineered mice, rats, and other animal models, as well as services such as breeding, housing, and phenotyping, can be lucrative. Additionally, advancements in CRISPR technology and the increasing focus on personalized medicine offer avenues for growth and differentiation in this market. Collaborations with academic institutions, research organizations, and pharmaceutical companies can also enhance market presence and drive innovation in the US Animal Model Market.
The US Animal Model Market is governed by various policies and regulations aimed at ensuring the ethical treatment and welfare of animals used in research. The primary legislation governing the use of animals in research is the Animal Welfare Act (AWA), enforced by the United States Department of Agriculture (USDA). This act sets forth guidelines for the housing, care, and treatment of animals in research settings. Additionally, institutions conducting research on animals must adhere to the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals, which requires the establishment of Institutional Animal Care and Use Committees (IACUCs) to oversee research protocols involving animals. These regulations are essential in upholding animal welfare standards and promoting ethical research practices within the US Animal Model Market.
The United States Animal Model Market is expected to witness steady growth in the coming years, driven by the increasing demand for preclinical testing in pharmaceutical and biotechnology research. With a rising focus on personalized medicine and drug development, the use of animal models for studying disease mechanisms and evaluating therapeutic interventions is projected to surge. Advancements in genetic engineering technologies, such as CRISPR-Cas9, are also anticipated to propel market growth by enabling the development of more precise and predictive animal models. Additionally, the growing prevalence of chronic diseases and the need for innovative treatment options are likely to further boost the demand for animal models in research. Overall, the US Animal Model Market is poised for expansion as the biopharmaceutical industry continues to invest in preclinical research and development.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Animal Model Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Animal Model Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Animal Model Market - Industry Life Cycle |
3.4 United States (US) Animal Model Market - Porter's Five Forces |
3.5 United States (US) Animal Model Market Revenues & Volume Share, By Animal Type , 2021 & 2031F |
3.6 United States (US) Animal Model Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United States (US) Animal Model Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 United States (US) Animal Model Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies |
4.2.2 Rising prevalence of chronic diseases requiring extensive research and drug development |
4.2.3 Technological advancements in genetic engineering and biotechnology |
4.3 Market Restraints |
4.3.1 Ethical concerns and regulatory restrictions related to animal testing |
4.3.2 High costs associated with maintaining animal facilities and procuring specific animal models |
4.3.3 Growing preference for alternative methods like in vitro testing and computational modeling |
5 United States (US) Animal Model Market Trends |
6 United States (US) Animal Model Market, By Types |
6.1 United States (US) Animal Model Market, By Animal Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Animal Model Market Revenues & Volume, By Animal Type , 2021 - 2031F |
6.1.3 United States (US) Animal Model Market Revenues & Volume, By Rat, 2021 - 2031F |
6.1.4 United States (US) Animal Model Market Revenues & Volume, By Mice, 2021 - 2031F |
6.1.5 United States (US) Animal Model Market Revenues & Volume, By Guinea Pigs, 2021 - 2031F |
6.1.6 United States (US) Animal Model Market Revenues & Volume, By Rabbits, 2021 - 2031F |
6.1.7 United States (US) Animal Model Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 United States (US) Animal Model Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Animal Model Market Revenues & Volume, By Drug Discovery & Development, 2021 - 2031F |
6.2.3 United States (US) Animal Model Market Revenues & Volume, By Basic Research, 2021 - 2031F |
6.2.4 United States (US) Animal Model Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 United States (US) Animal Model Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Animal Model Market Revenues & Volume, By Pharma & Biotech Companies, 2021 - 2031F |
6.3.3 United States (US) Animal Model Market Revenues & Volume, By Academic Research Institutes, 2021 - 2031F |
6.3.4 United States (US) Animal Model Market Revenues & Volume, By Others, 2021 - 2031F |
7 United States (US) Animal Model Market Import-Export Trade Statistics |
7.1 United States (US) Animal Model Market Export to Major Countries |
7.2 United States (US) Animal Model Market Imports from Major Countries |
8 United States (US) Animal Model Market Key Performance Indicators |
8.1 Number of new drug approvals correlated with animal model research |
8.2 Adoption rate of advanced animal models (e.g., humanized mice, genetically modified animals) |
8.3 Research funding allocated to animal model studies |
9 United States (US) Animal Model Market - Opportunity Assessment |
9.1 United States (US) Animal Model Market Opportunity Assessment, By Animal Type , 2021 & 2031F |
9.2 United States (US) Animal Model Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United States (US) Animal Model Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 United States (US) Animal Model Market - Competitive Landscape |
10.1 United States (US) Animal Model Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Animal Model Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |